Blood clot devices are used to dissolve the blood clots formed in a vein or artery. Blood clots disrupt the delivery of oxygen-rich blood to the brain due to blockage in the artery, which leads to ischemic strokes. These blood clots can travel to the lungs from the legs or other parts of the body as well. The clot management devices are used to prevent potential ischemic strokes, heart attack and sever legs pain by eliminating these blood clots from the artery. The growth of the global clot management devices market can be attributed to the increasing demand for effective thrombectomy devices and rising number of lifestyle diseases due to smoking, lack of physical activity and obesity. Moreover, the increasing adoption of percutaneous devices instead of open surgical procedures likely to add novel opportunities for the global clot management devices market over the forecast period.
The "Global Clot Management Devices Market Analysis to 2025" is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global clot management devices market with detailed market segmentation by product, end user and geography. The global clot management devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
On the basis of product, the market is segmented into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices and inferior vena cava filters (IVCF). The percutaneous thrombectomy devices segment is further segmented into mechanical thrombectomy, aspiration thrombectomy and percutaneous mechanical thrombectomy (PMT). The inferior vena cava filters (IVCF) segment also bifurcated into Permanent IVCF and Retrievable IVCF. Based on end user, the clot management devices market is classified as hospitals, ambulatory surgical centers, diagnostic centers and others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global clot management devices based on product and end user. It also provides market size and forecast till 2025 for overall clot management devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East &Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to dominate the clot management devices market in the global arena due to increasing technological advancements and rising prevalence of periphery artery disease in the region. However, the Asia-Pacific region is anticipated to show a significant growth rate over the next few years in the global clot management devices market due to increasing aging population and rising awareness in the region. The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key clot management devices manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Cook, Medtronic, Boston Scientific Corporation, Teleflex Incorporated, AngiDynamics, Stryker, iVascular SLU., Edwards Lifesciences Corporation, Straub Medical AG, LeMaitre Vascular, Inc. among others.
About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: